MARC details
| 000 -LEADER |
|---|
| fixed length control field |
01823cam a2200349 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
4926565 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20201006142007.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
950822s1996 enka b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
0471957135 (alk. paper) |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DLC |
| Description conventions |
rda |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| Language of cataloging |
eng |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.7882 |
| Edition number |
20 |
| Item number |
C.N.A |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Cutler, Neal R. |
| 9 (RLIN) |
8812 |
| Relator term |
author. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Anxiolytic compounds : |
| Remainder of title |
perspectives in drug development / |
| Statement of responsibility, etc |
Neal R. Cutler and John J. Sramek, Neil M. Kurtz. |
| 264 #1 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Chichester ; |
| -- |
New York : |
| Name of publisher, distributor, etc |
John Wiley, |
| Date of publication, distribution, etc |
[1996] |
| 264 #4 - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Date of publication, distribution, etc |
copyright 1996 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
viii, 163 pages : |
| Other physical details |
illustrations ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content type term |
text |
| Content type code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media type term |
unmediated |
| Media type code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier type term |
volume |
| Carrier type code |
nc |
| Source |
rdacarrier |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Erratum slip inserted. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Preface <br/> Abbreviations used in the Text <br/>1 Perspectives On the Worldwide Market for Anxiolytics 1<br/>2 A Retrospective Analysis of the Drug Development of Currently Approved Anxiolytics 31<br/>3 Methodological Issues in Drug Development 61<br/>4 Novel Anxiolytics 109<br/>5 Role of the 'Bridging' Study in Facilitating Development of Potential Anxiolytics 139<br/>6 Perspectives on International Regulatory Requirements 153<br/> Concluding Remarks 157<br/> Index |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Tranquilizing drugs |
| General subdivision |
Development. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Sramek, John J. |
| 9 (RLIN) |
8814 |
| Relator term |
author. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Kurtz, Neil M. |
| 9 (RLIN) |
8815 |
| Relator term |
author. |
| 856 42 - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Publisher description |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/description/wiley031/95039622.html">http://www.loc.gov/catdir/description/wiley031/95039622.html</a> |
| 856 4# - ELECTRONIC LOCATION AND ACCESS |
|---|
| Materials specified |
Table of Contents |
| Uniform Resource Identifier |
<a href="http://www.loc.gov/catdir/toc/onix02/95039622.html">http://www.loc.gov/catdir/toc/onix02/95039622.html</a> |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ocip |
| f |
19 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
Dewey Decimal Classification |
| Koha item type |
Books |